Profile for Sarepta Therapeutics Inc. (SRPT)

$ 144.53   0.50 (+0.35%) Volume: 1.43m 4:00 PM EDT Sep 18, 2020
After Hours:  $ 145.85   1.32 (+0.91%) Volume: 117.45k 5:42 PM EDT Sep 18, 2020
Business Description:
Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
Address: 215 First Street, Suite 415, Cambridge, MA, US, 02142
Telephone: +1 617 274-4000 Website: https://www.sarepta.com
Facsimile: +1 800 621-5203 Email: [email protected]
Details
CEO: Douglas S. Ingram
Employees: 743 Market Cap: 11.35b
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 873303
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)